Table 2 Demographic data of the patients (total = 34)
From: Peroral Endoscopic Myotomy (POEM) for the treatment of achalasia in an Egyptian cohort
Age (years) | |
Range | 11–68 |
Median (IQR) | 33.5 (27) |
Gender (Number, %) | |
Female | 15 (44.1%) |
Male | 19 (55.9%) |
Comorbidities | |
Diabetes | 1 (2.9%) |
Hypertension | 2 (5.9%) |
3A syndromea | 1 (2.9%) |
Hypothyroidism | 1 (2.9%) |
Thyrotoxicosis | 1 (2.9%) |
Ischemic heart disease | 1 (2.9%) |
Renal impairment | 1 (2.9%) |
COPD | 1 (2.9%) |
BMIb | |
Range | 13.3–37.6 |
Median (IQR)c | 23.7 (10.2) |
Disease duration (years) | |
Range | 0.5–16 |
Median (IQR) | 3 (3) |
Type of achalasia | |
Type 1 | 12 (35.2%) |
Type 2 | 18 (52.9%) |
Type 3 | 4 (11.7%) |
IRP (4sd | |
Range | 11.5—49.4 |
Median (IQR) | 25.6 (19.5) |
Previous therapies (number, %) | |
Surgery | 1 (3.2%) |
Endoscopic dilation | 16 (47.1%) |
1 Session of dilation | 9 (26.5%) |
2 Sessions of dilation | 4 (11.5%) |
3 Sessions of dilation | 2 (5.9%) |
6 Sessions of dilation | 1 (2.9%) |
Eckardt score | 4–12 |
Range | 9 (3) |
Median (IQR) | |